bioTheranostics, Prime Health Services sign contract to expand genomic tests

[News]

bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, has signed a contract with Prime Health Services, Inc., a national preferred provider organization network, to cover the company's genomic tests for breast cancer patients and patients with metastatic disease.

More... (http://www.news-medical.net/news/20140409/bioTheranostics-Prime-Health-Services-sign-contract-to-expand-genomic-tests.aspx)